Hans Adolf Krebs Award for Fabian Eichelmann
Dr. Fabian Eichelmann from the DZD partner German Institute of Human Nutrition Potsdam-Rehbrücke (Deutsches Institut für Ernährungsforschung, DIfE) was honored at the 62nd Scientific Congress of the German Nutrition Association (Deutsche Gesellschaft…
Interdisciplinary Long Covid Symposium by DZG
The 2nd Long COVID Symposium of the German Centers for Health Research (DZG) will take place in Francfort/Main on May 9, 2025. The event in the Senckenberg Museum brings together leading experts to discuss the latest findings on Long COVID. This…
DZD Workshop
New Study: How Are Insulin-Producing Beta Cells Formed?
A research team led by Prof. Henrik Semb, Director of the Institute of Translational Stem Cell Research at the DZD partner Helmholtz Munich, has gained new insights into how immature pancreatic cells decide whether to become insulin-producing beta…
DZD NEXT Symposium
More Precise Treatment of Fatty Liver Diseases
Almost one in three adults worldwide suffers from fatty liver disease, also known as metabolic dysfunction-associated fatty liver disease (MASLD). MASLD can lead to serious liver diseases such as cirrhosis and liver cancer and increases the risk of…
Clusters of Metabolic Dysfunction-Associated Steatotic Liver Disease for Precision Medicine
Tübingen / Verona
Globally more than 30% of the adult population has metabolic dysfunction-associated steatotic liver disease (MASLD). People with MASLD and more so with metabolic dysfunction-associated steatohepatitis (MASH) and MASLD-associated…
New on diabinfo.de: Comprehensive Information on Obesity
One in four adults in Germany has severe overweight. Many of those affected suffer from the health consequences of obesity and its complications – such as type 2 diabetes, cardiovascular disease, arthritis and mental illness. Just in time for Obesity…
Research Prize of the Dr. Heinz Bürger-Büsing Foundation for Michael Roden
DZD Speaker Prof. Dr. Michael Roden was awarded the Dr. Heinz Bürger-Büsing Foundation Research Prize for his pioneering scientific research into the pathogenesis and prevention of complications of diabetes mellitus.
Inter-Organ Metabolomics: New Metabolic Mechanisms are Explored
The DZD partner Helmholtz Munich has successfully secured funding from the third DZG innovation fund for "Inter-Organ Metabolomics". Led by Dr. Maria Rohm, an interdisciplinary research team will explore how metabolic byproducts in individuals with…
Obesity Starts in the Brain
A study by the University Hospital of Tübingen, Helmholtz Munich and the German Center for Diabetes Research (DZD) has provided new insights into the role of the brain as a crucial control center and the origin of obesity and type 2 diabetes. The…
Tübingen Study: The Brain Plays a Central Role in the Development of Obesity
Tübingen
The number of obese persons has grown significantly in recent decades, which presents significant difficulties for those who are impacted, healthcare systems, and those who provide treatment. The hormone insulin plays a key role in the…
Potsdam: Open Professorship at the DIfE
The DZD partner German Institute for Human Nutrition (DIfE) has a vacancy for a full professorship (W 3) for Diabetology and Nutrition.
German Centers for Health Research at the NUM Convention 2025
Under the motto “Cooperation in NUM: Breaking new ground in an interdisciplinary and multicenter way”, the Network of University Medicine (NUM) is hosting the NUM Convention on February 25 and 26, 2025. Experts from the German Centers for Health…
Remission of Prediabetes Reduces the Risk of Type 2 Diabetes
A growing number of people have elevated blood sugar values, which is known as prediabetes, a precursor to type 2 diabetes. In a review article, researchers from the German Center for Diabetes Research (DZD) and the University of Tübingen emphasize…
Prediabetes Remission Reduces the Risk of Type 2 Diabetes
Tübingen
A growing number of people have elevated blood sugar values, which is known as prediabetes, a precursor to type 2 diabetes. In a review article, DZD researchers from the Institute for Diabetes Research and Metabolic Diseases (IDM) of…
New Findings on Insulin Action: Potential for Type 2 Diabetes Therapies Discovered
Researchers at the German Diabetes Center (DDZ), Heinrich Heine University Düsseldorf (HHU) and the German Center for Diabetes Research (DZD) have for the first time studied the temporal course of insulin action on protein kinases in human muscle…
New Insights into Insulin Action: Dynamic Signaling Network Offers Therapeutic Approaches for Type 2 Diabetes
Düsseldorf
Researchers from the German Diabetes Center (DDZ) and the Heinrich Heine University Düsseldorf (HHU) have studied the temporal pattern of insulin action on protein kinases in human muscle cells in detail for the first time. Their findings…
Intermittent Fasting in Adolescents Could Impair the Metabolism
Age plays an important role in long-term intermittent fasting. Researchers from Helmholtz Munich, the Technical University of Munich (TUM), Ludwig Maximilians University Munich (LMU) and the German Center for Diabetes Research (DZD) have discovered…
A Future Without Needles: Optical Glucose Monitoring for Diabetes
In an article in ‘Nature Metabolism’, Andreas L. Birkenfeld and Vasilis Ntziachristos discuss advances in non-invasive glucose monitoring for people with diabetes. Optical measurements through the skin are difficult because they often only show…
Comparison of Hybrid Closed Loop and Open Loop Systems in Type 1 Diabetes
In comparison with open-loop systems, hybrid closed-loop systems improve blood sugar control in people with type 1 diabetes, lower the HbA1c level, and increase the percentage of time in the target glucose range. This is shown by a cohort study with…
Type 1 Diabetes: Hybrid Closed-Loop and Open-Loop Systems Compared
Aachen / Ulm
People with type 1 diabetes require continuous insulin treatment and must regularly measure their glucose levels. With open-loop therapies*, insulin administration is manually controlled, while hybrid closed-loop systems* automatically…
Guideline of the German Medical Association for Quality Assurance of Laboratory Medical Examinations (Rili-BÄK) - Table B1.1 (page 11) - Determination of glucose and potassium in vitro
Letter to Dr. med. Klaus Reinhardt and the Board of the German Medical Association: Please do not resume glucose determinations in serum. The current DDG practice recommendations clearly state that glucose measurements for diabetes diagnostics should…
DZG Lunchtime Career Talk: Funding your own research group
Regulator of Glucose and Lipid Metabolism Discovered
Physical activity is not only important for fitness, but also for health. This is confirmed by a new study conducted under the direction of Prof. Dr. Maximilian Kleinert at the German Institute of Human Nutrition Potsdam-Rehbrücke (DIfE). His team…
PanK4 Identified as a Regulator of Glucose and Lipid Metabolism
Potsdam-Rehbrücke
Physical activity is not only important for fitness, but also for health. This is confirmed by a new study conducted under the direction of Prof. Dr. Maximilian Kleinert at the German Institute of Human Nutrition Potsdam-Rehbrücke…
Proposal to Revise the Obesity Diagnosis
The international Commission on Clinical Obesity is proposing a major revision of the diagnosis of obesity. The new approach goes beyond body mass index (BMI) and includes additional measurements of body fat as well as objective symptoms at the…
International Commission Proposes Major Revision of Obesity Diagnosis
Dresden
The international Commission on Clinical Obesity is proposing a major revision of the diagnosis of obesity. The new approach goes beyond body mass index (BMI) and includes additional measurements of body fat as well as objective symptoms at…
Prediabetes Study: Biomarkers as the Key to Predicting the Development of the Disease
People with prediabetes often develop diabetes, but many of them manage to reverse to normoglycemia. What determines these distinct outcomes? Can we identify biomarkers to predict the different trajectories of prediabetes? To address the questions…
Identification of Novel Marker Candidates Associated with the Progression of Prediabetes to Diabetes or Its Remission to Normoglycemia
Dresden
People with prediabetes often develop diabetes, but many of them manage to reverse to normoglycemia. What determines these distinct outcomes? Can we identify biomarkers to predict the different trajectories of prediabetes? To address the…
Precision Prevention for People at Increased Risk of Diabetes and Cardiovascular Disease
Cardiovascular disease is one of the most common complications of type 2 diabetes. People with prediabetes may already be at increased risk of these complications. DZD board member Andreas Birkenfeld, together with diabetes specialists Paul Franks…
Heterogeneity of Metabolic Dysfunction-associated Steatotic Liver Disease
About 70 percent of obese people have metabolic dysfunction-associated steatotic liver disease (MASLD). However, MASLD is also found in lean people. Paradoxically, some effective pharmacological approaches to improve liver health in people with MASLD…
New Project to Improve the Diagnosis and Treatment of Pancreatic Cancer
Pancreatic ductal adenocarcinoma (PDAC) is expected to be the second most common cause of cancer-related deaths in Europe by 2040. In order to improve the diagnosis and treatment of this type of cancer, a new international research project led by…
Newly Funded “EP Permed” Project Targets Pancreatic Cancer Diversity for Better Diagnosis and Treatment
Dresden
Pancreatic ductal adenocarcinoma (PDAC) is expected to become the second-leading cause of cancer-related deaths in Europe by 2040. Unlike other types of cancer, survival rates for pancreatic cancer have barely improved over the past 50 years,…
Diabetes Subtypes Have Different Risks for Depression Symptoms and Reduced Well-being
Diabetes subtypes also differ in terms of depression symptoms, health-related quality of life, well-being and the perception of diabetes-related stress. This is indicated by studies conducted by DZD researchers. The results were published in 'The…
Diabetes Subtypes Differ in Terms of Well-being, Depression Symptoms and Their Health-related Quality of Life
Düsseldorf
The motto of this year's World Diabetes Day on November 14 is “Diabetes and Well-being.” Researchers at the German Diabetes Center (DDZ) have conducted studies on the well-being and quality of life of people with diabetes and published…
Could the Food Additive Carrageenan Increase the Risk of Type 2 Diabetes?
The food additive carrageenan (E 407) can be responsible for the development of chronic inflammatory bowel disease, ulcers, and increased blood sugar levels in animals. DZD researchers have now investigated the effects of carrageenan on the human…
The Food Additive Carrageenan Could Disrupt the Intestinal Barrier
Düsseldorf / Tübingen
The food additive carrageenan (E 407) can be responsible for the development of chronic inflammatory bowel disease, ulcers, and increased blood sugar levels in animals. DZD researchers have now investigated the effects of…
New Approach for Diabetes Therapies: Inceptor Regulates Insulin Homeostasis
In 2021, a research team led by Prof. Heiko Lickert from Helmholtz Munich discovered the insulin-inhibitory receptor "Inceptor" and its role as a suppressor of the insulin signaling pathway. Now, the researchers have unlocked another, even more…
Active In Informing During Diabetes Awareness Month
November is Diabetes Awareness Month, a time dedicated to raising awareness of diabetes and supporting people with diabetes. With numerous events, symposia and information stands, the researchers of the DZD and the diabinfo.de team provided…
Anette Ziegler in the Podcast: Recognizing Type 1 Diabetes Earlier and Even Stopping It
DZD scientist Prof. Dr. Anette-Gabriele Ziegler reports on current research approaches to detect type 1 diabetes early or even prevent it in the Diabetes Anchor Podcast.
Inceptor Regulates Insulin Homeostasis: A New Approach for Diabetes Therapies
Neuherberg
In 2021, a research team led by Prof. Heiko Lickert from Helmholtz Munich discovered the insulin-inhibitory receptor "Inceptor" and its role as a suppressor of the insulin signaling pathway. Now, the researchers have unlocked another, even…
diabinfo.de and at the Diabetes Autumn Conference: Target Group-Oriented Prevention, Therapy and Education
At the Diabetes Autumn Conference of the DDG (November 22 and 23) in Hanover, the diabetes information portal diabinfo.de will have a stand with practical tips on preventing and managing diabetes. Current research results from the German Center for…
DDG Autumn Meeting
Strategy and Communication in the Focus of the Advisory Board Meeting
The most recent meeting of the Citizen and Patient Advisory Board of the German Center for Diabetes Research (DZD) focused on strategy and communication. A great deal of progress has been made since the last meeting, which also takes into account the…
Milestones of modern Diabetology
Activities and Events for World Diabetes Day
Around World Diabetes Day on November 14, numerous events will once again draw attention to the metabolic disease. The DZD and the national diabetes information portal diabinfo.de are also taking part. For example, diabinfo.de will be presenting its…
diabinfo.de at BZgA Town Hall for Health Authorities
To mark World Diabetes Day on November 14, the Federal Center for Health Education (BZgA) is hosting a town hall meeting on the topic of “Preventing diabetes”. The national diabetes information portal diabinfo.de will also be presented at this online…
Updated S3 Guideline on the “Prevention and Treatment of Obesity”
The updated version of the S3 guideline on “Prevention and treatment of obesity” has been published. The new guideline takes greater account of the fact that obesity is a chronic disease that requires long-term, often lifelong treatment.
Panel Discussion at the Urania: Is Sugar Addictive?
DZG Magazine SYNERGIE: Focus on Intelligent Medicine
Analyzing large amounts of data makes it possible to diagnose, treat or even prevent common diseases more precisely. The current issue of SYNERGIE describes the research approaches being pursued by the German Centers for Health Research (DZG).
German Diabetes Center (DDZ) in Düsseldorf celebrates its 60th anniversary
The DZD partner German Diabetes Center in Düsseldorf is celebrating its 60th birthday with a ceremony on 29th October.
Beta Cells: New Insights into the Structure, Interactions and Neuronal Networking of Primary Cilia
Dysfunctions of the tiny cell processes (primary cilia*) of the pancreatic beta cells could be a cause of type 2 diabetes. Little is known about the structure and function of these cilia. An international research team led by DZD researchers from the…
DIfE Celebrates 30 Years of the EPIC Potsdam Study
On October 21, 2024, a celebratory symposium to mark the 30th anniversary of the EPIC Potsdam Study took place at the German Institute of Human Nutrition (DIfE). Also known as the Brandenburg Nutrition and Cancer Study, the prospective cohort study…
Beta Cells: New Insights into the Structure, Interactions and Neuronal Networking of Primary Cilia
Desden
Dysfunctions of the tiny cell processes (primary cilia*) of the pancreatic beta cells could be a cause of type 2 diabetes. Little is known about the structure and function of these cilia. An international research team led by DZD researchers…
DIfE Celebrates 30 Years of the EPIC Potsdam Study
Potsdam-Rehbrücke
On October 21, 2024, a celebratory symposium to mark the 30th anniversary of the EPIC Potsdam Study took place at the German Institute of Human Nutrition (DIfE). Also known as the Brandenburg Nutrition and Cancer Study, the…
DZD Workshop
Helmholtz Munich at Bergson: The Weight Loss Syringe – The End to Obesity and Diabetes?
diabinfo in Dialog 2024: Diabetes, Heart Health and the Psyche
Prof. Knut Mai Takes Over the Clinic for Endocrinology and Metabolic Medicine
Prof. Knut Mai, who is project partner at the DZD, acceded to the professorship for internal medicine with a focus on endocrinology and diabetology at the Charité – Universitätsmedizin Berlin on October 1. This position is associated with the…
DZD Researcher Olga Ramich at Doc Fischer on Metabolism and Sleep
Prof. Dr. Olga Ramich from the DZD partner German Institute of Human Nutrition (DIfE) explained the connections between metabolism and sleep in the SWR television program DocFischer on the topic “Nutrition in the evening: Which foods are best for…
Weight Loss Due to Glucagon-like Peptide-1 Receptor Agonists: Effects on Muscle Health
Muscle Mass and Glucagon-Like Peptide-1Receptor Agonists: Adaptive or Maladaptive Response to Weight Loss?
Circulation 2024
Effect of Treatment with Receptor Agonists on Muscle Mass
Through treatment with glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and combination therapies, e.g. semaglutide or tirzepatide, persons with type 2 diabetes or obesity can significantly reduce their weight. But how does this significant…
Annual Meeting of the German Obesity Association
Helmholtz Health Summit
Prof. Dr. Michael Roden Receives Silver Medal of Honor of the City of Vienna
DZD speaker Prof. Dr. Michael Roden was awarded the Silver Medal of Honor for his many years of special service to the state of Vienna. With this award, the City of Vienna honors people who have made special contributions to the country through their…
Helmholtz Munich Opened Its Doors for "The Mouse"
Every year on October 3rd, the German broadcaster WDR organizes the event "Doors Open with The Mouse." This year, 770 companies and research institutions across Germany participated, welcoming children and parents under the theme "Working Together."…
diabinfo in Dialog 2024: Diabetes, Heart Health and the Psyche
Many people with type 1 and type 2 diabetes struggle with concomitant cardiovascular diseases and their mental well-being is also often affected. How do high blood sugar levels affect the cardiovascular system? And how can people with diabetes and…
Digital Forum „diabinfo im Dialog“ 2024: Diabetes and Cardiovascular Disease - Don't Ignore the Mind
Neuherberg
On October 21, the national diabetes information portal diabinfo.de invites you to the virtual event “diabinfo in dialog”. Many people with type 1 and type 2 diabetes struggle with concomitant cardiovascular diseases and their mental…
DZD Scientist Anette-Gabriele Ziegler Receives Rachmiel Levine Medal
Prof. Anette-Gabriele Ziegler, Director of the Institute of Diabetes Research at DZD partner Helmholtz Munich, was awarded the Rachmiel Levine Medal 2024 by City of Hope. This award recognizes her outstanding contributions to the understanding and…
Study Shows no Negative Effects of Religious Dry Fasting on Blood Sugar Levels in People Without Diabetes
A team of researchers led by Prof. Dr. Olga Ramich from the DZD partner German Institute of Human Nutrition Potsdam-Rehbrücke (DIfE) and the Charité – Universitätsmedizin Berlin has investigated the effects of religious dry fasting and…
DDEA Postdoc Summit 2024
GAIN24 Digital Workshop: Network as a Career Factor
How interdisciplinary and cross-institutional research networks promote careers in science is the focus of the GAIN24 digital workshop on September 19. Experts from the German Centers for Health Research will be among those presenting career paths.
Key Protein for Improved Glucose Transport in Adipose Tissue Identified
Researchers from the German Institute of Human Nutrition Potsdam-Rehbruecke (DIfE), the German Center for Diabetes Research (DZD), ETH Zurich and the University of Cambridge have studied the role of the protein PICALM in white adipose tissue. They…
Novel Regulator of Glucose Transport in Adipose Tissue Discovered
Potsdam-Rehbrücke
The role of the adapter protein PICALM in the development of Alzheimer's disease is well documented. Researchers from the German Institute of Human Nutrition Potsdam-Rehbruecke (DIfE), the German Center for Diabetes Research (DZD),…
DZG Lunchtime Career Talk: Bridging Science and Strategy (Science Management)
Advanced training: Innovations in Internal Medicine
Development of novel hPS reporter cell lines for the improvement of diabetes stem cell therapies
Human pluripotent stem (hPS) cells can differentiate into any cell type in the human body, including pancreatic islet cells. The current methods used to differentiate hPS cells into mature, insulin-producing beta cells are not efficient or consistent…
Development of Novel hPS Reporter Cell Lines for the Improvement of Diabetes Stem Cell Therapies
Dresden
Human pluripotent stem (hPS) cells can differentiate into any cell type in the human body, including pancreatic islet cells. The current methods used to differentiate hPS cells into mature, insulin-producing beta cells are not efficient or…
ERC-Starting-Grant and Appointment to the Leopoldina for Michael Laxy
The European Research Council is funding DZD scientist Prof. Dr. Michael Laxy and his EcIMPACT project with an ERC Starting Grant of 1.5 million euros over the next five years. Laxy was also appointed to the Leopoldina's obesity working group.
Joint statement by the German Society of Endocrinology (DGE), the German Diabetes Association (DDG) and the German Center for Diabetes Research (DZD) on the draft bill to amend the Animal Welfare Experimental Animal Ordinance
The executive boards of the German Society of Endocrinology (DGE), the German Diabetes Association (DDG) and the German Center for Diabetes Research (DZD) comment on the draft amendment to the Animal Welfare Experimental Animal Ordinance as part of…
12th DZD Diabetes Research School
New Podcast Episode: Prediabetes Remission and Prevention of Type 2 Diabetes
In the latest episode of O-Ton Diabetologie, DZD Director Prof Dr Andreas Birkenfeld talks about the important steps to prevent the development of prediabetes into type 2 diabetes and how prediabetes remission can be achieved.
Diabetes Risk: Fat Alone Does Not Cause Changes in the Hypothalamus
Acute elevated dietary fat alone is not sufficient to decrease AgRP projections in the paraventricular nucleus of the hypothalamus in mice.
Scientific Reports 2024
DDEA Summer School
Subjective Perception of Blood Glucose Control is Decisive for Psychological Complaints
Perceived glucose levels matter more than CGM-based data in predicting diabetes distress in type 1 or type 2 diabetes: a precision mental health approach using n-of-1 analyses.
Diabetologia 2024
Diabetes Summer Tour 2024
Molecular Effects of Bariatric Surgery on Obesity and Type 2 Diabetes
Researchers at the DZD have gained new insights into the molecular adaptations in skeletal muscle after bariatric surgery in obese patients with and without type 2 diabetes. They have published their findings in the journal “Diabetes & Metabolism.”…
New Molecular Insights into the Effects of Bariatric Surgery on Obesity and Type 2 Diabetes
Potsdam-Rehbrücke
Researchers at the German Institute of Human Nutrition Potsdam-Rehbrücke (DIfE) and the German Center for Diabetes Research (DZD) have gained new insights into the molecular adaptations in skeletal muscle after bariatric surgery in…
New Position Paper on the Early Detection of Type 1 Diabetes
A new position paper published by experts from the Fr1daPlex initiative, the Bavarian Association of Pediatricians (BVKJ) and PaedNetz Bayern e.V. underlines the importance of islet autoantibody screening for the early detection of type 1 diabetes in…
2nd DZG Munich Day: Working Together to Move More Quickly from Bench to Bedside
More than 170 researchers and clinicians from the eight German Centers for Health Research (DZGs) and invited guests from the world of politics shared insights on current DZG research projects at the 2nd DZG Munich Day in Munich on July 12, 2024.…
Humboldt Foundation Award for DZD Scientist Sheikh
Dr. Bilal Sheikh, group leader of the Young Investigator’s group “Vascular Epigenetics” at the Institute for Metabolic, Obesity and Vascular Research of the DZD partner Helmholtz Munich, has been selected as a Henriette-Herz Scout by the Alexander…
One Drop of Blood for Many Diagnoses
Using infrared light and machine learning, researchers from the attoworld team have developed a method to investigate the health status of a population. Scientists from Ludwig-Maximilians-Universität München, the Max Plack Institute of Quantum Optics…
DZG Science and Career Day at the DIfE
Summer School of Epidemiology
60th Annual Meeting of the EASD
Prediabetes Remission for Type 2 Diabetes Prevention
Current medical guidelines recommend that people in a preliminary stage of type 2 diabetes lose at least 7 percent of their body weight in order to prevent manifest diabetes. In an article in “Nature Reviews Endocrinology,” DZD experts Prof. Andreas…
Symposium Paul Martini Foundation: RNA-based therapies
Prediabetes Remission for Type 2 Diabetes Prevention
Tübingen
Current medical guidelines recommend that people in a preliminary stage of type 2 diabetes lose at least 7 percent of their body weight in order to prevent manifest diabetes. In an article in “Nature Reviews Endocrinology,” diabetes experts…